BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 17258777)

  • 1. Comparative measurement of spinal CSF microdialysate concentrations and concomitant antinociception of morphine and morphine-6beta-glucuronide in rats.
    Okura T; Komiyama N; Morita Y; Kimura M; Deguchi Y; Yamada S
    Life Sci; 2007 Mar; 80(14):1319-26. PubMed ID: 17258777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different distribution of morphine and morphine-6 beta-glucuronide after intracerebroventricular injection in rats.
    Okura T; Saito M; Nakanishi M; Komiyama N; Fujii A; Yamada S; Kimura R
    Br J Pharmacol; 2003 Sep; 140(1):211-7. PubMed ID: 12967951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different effects of morphine and morphine-6beta-glucuronide on formalin-evoked spinal glutamate release in conscious and freely moving rats.
    Okura T; Komiyama N; Morita Y; Kimura M; Yamada S
    Neurosci Lett; 2007 Mar; 415(2):169-73. PubMed ID: 17267124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of old age on the disposition and antinociceptive response of morphine and morphine-6 beta-glucuronide in the rat.
    Van Crugten JT; Somogyi AA; Nation RL; Reynolds G
    Pain; 1997 Jun; 71(2):199-205. PubMed ID: 9211481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased CNS uptake and enhanced antinociception of morphine-6-glucuronide in rats after inhibition of P-glycoprotein.
    Lötsch J; Schmidt R; Vetter G; Schmidt H; Niederberger E; Geisslinger G; Tegeder I
    J Neurochem; 2002 Oct; 83(2):241-8. PubMed ID: 12423235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concentration-effect relationships of morphine and morphine-6 beta-glucuronide in the rat.
    van Crugten JT; Somogyi AA; Nation RL; Reynolds G
    Clin Exp Pharmacol Physiol; 1997 May; 24(5):359-64. PubMed ID: 9143788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated concentrations of morphine 6-beta-D-glucuronide in brain extracellular fluid despite low blood-brain barrier permeability.
    Stain-Texier F; Boschi G; Sandouk P; Scherrmann JM
    Br J Pharmacol; 1999 Oct; 128(4):917-24. PubMed ID: 10556926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Morphine-6-glucuronide is responsible for the analgesic effect after morphine administration: a quantitative review of morphine, morphine-6-glucuronide, and morphine-3-glucuronide.
    Klimas R; Mikus G
    Br J Anaesth; 2014 Dec; 113(6):935-44. PubMed ID: 24985077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apparent insensitivity of the hotplate latency test for detection of antinociception following intraperitoneal, intravenous or intracerebroventricular M6G administration to rats.
    South SM; Smith MT
    J Pharmacol Exp Ther; 1998 Sep; 286(3):1326-32. PubMed ID: 9732396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analgesic response and plasma and brain extracellular fluid pharmacokinetics of morphine and morphine-6-beta-D-glucuronide in the rat.
    Stain F; Barjavel MJ; Sandouk P; Plotkine M; Scherrmann JM; Bhargava HN
    J Pharmacol Exp Ther; 1995 Aug; 274(2):852-7. PubMed ID: 7636748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of 12-oxochenodeoxycholate on the pharmacokinetics and pharmacodynamics of morphine 6-glucuronide in Wistar rats.
    Yang L; Fawcett JP; Zhang H; Tucker IG
    J Pharm Pharmacol; 2013 Apr; 65(4):561-6. PubMed ID: 23488785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pharmacokinetics of morphine and morphine glucuronide metabolites after subcutaneous bolus injection and subcutaneous infusion of morphine.
    Stuart-Harris R; Joel SP; McDonald P; Currow D; Slevin ML
    Br J Clin Pharmacol; 2000 Mar; 49(3):207-14. PubMed ID: 10718775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intestinal absorption and stability of morphine 6-glucuronide in different physiological compartments of the rat.
    Stain-Texier F; Sandouk P; Scherrmann JM
    Drug Metab Dispos; 1998 May; 26(5):383-7. PubMed ID: 9571218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concentrations of morphine and morphine metabolites in CSF and plasma during continuous subcutaneous morphine administration in cancer pain patients.
    Wolff T; Samuelsson H; Hedner T
    Pain; 1996 Dec; 68(2-3):209-16. PubMed ID: 9121807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of morphine-6-glucuronide antinociception after morphine treatment. Is morphine-3-glucuronide involved?
    Faura CC; Olaso JM; Cabanes CG; Horga JF
    Pain; 1996 Apr; 65(1):25-30. PubMed ID: 8826486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analgesic efficacy and CSF pharmacokinetics of intrathecal morphine-6-glucuronide: comparison with morphine.
    Hanna MH; Peat SJ; Woodham M; Knibb A; Fung C
    Br J Anaesth; 1990 May; 64(5):547-50. PubMed ID: 2354092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic modelling of morphine, morphine-3-glucuronide and morphine-6-glucuronide in plasma and cerebrospinal fluid of neurosurgical patients after short-term infusion of morphine.
    Meineke I; Freudenthaler S; Hofmann U; Schaeffeler E; Mikus G; Schwab M; Prange HW; Gleiter CH; Brockmöller J
    Br J Clin Pharmacol; 2002 Dec; 54(6):592-603. PubMed ID: 12492606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An observational study examining the effects of a surgically induced inflammatory response on the distribution of morphine and its metabolites into cerebrospinal fluid.
    Wang Y; Goralski KB; Roberts DJ; Landry K; Issa ME; Sleno L; Julien LC; Wood J; Hall RI
    Can J Anaesth; 2017 Oct; 64(10):1009-1022. PubMed ID: 28710563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood-brain barrier transport and brain distribution of morphine-6-glucuronide in relation to the antinociceptive effect in rats--pharmacokinetic/pharmacodynamic modelling.
    Bouw MR; Xie R; Tunblad K; Hammarlund-Udenaes M
    Br J Pharmacol; 2001 Dec; 134(8):1796-804. PubMed ID: 11739257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebrospinal fluid and plasma concentrations of morphine, morphine-3-glucuronide, and morphine-6-glucuronide in patients before and after initiation of intracerebroventricular morphine for cancer pain management.
    Smith MT; Wright AW; Williams BE; Stuart G; Cramond T
    Anesth Analg; 1999 Jan; 88(1):109-16. PubMed ID: 9895076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.